24/08/2026
serious side effects are a major reason we don't yet screen for prostate cancer - reducing them makes it far more likely we can get to a screening programme for all men sooner. That's why all men diagnosed through the TRANSFORM screening study will be able to choose focal therapy if it's appropriate to treat their cancer
As new data shows focal therapies are safe and effective at treating most early prostate cancers, we're pushing NICE to review the evidence for men across the UK to have access the treatments.